Press ReleasesKanvas Receives Strategic Investment from Btomorrow Ventures, A Division...

Kanvas Receives Strategic Investment from Btomorrow Ventures, A Division Of BAT, As Lead Investor

-

THE Kanvas Co. (“Kanvas”), developer of patented electronic vaporizer technology solutions designed to deliver device safety, performance, and reliability for nicotine, cannabis, and cannabidiol (CBD) delivery systems, today announced the completion of a strategic investment (the ”Investment”). The Investment was led by Btomorrow Ventures (BTV), the corporate venturing unit of British American Tobacco (BAT). The terms of the transaction were not disclosed.

The new investment will fuel the research, development, and growth necessary to commercialize Kanvas’s proprietary Vapetelligence™ technology platform and further enable scalability of its innovative products, designed to promote device safety in electronic vaporizers and regulated marketplaces globally. 

“Kanvas is excited to work with BTV as a strategic investor to advance the commercialization of our unique IP portfolio and technology platform, focusing on our patented and temperature-controlled dosing technology and hardware that provides a secure and controlled delivery system for brands,” said Andy Fathollahi, CEO, Kanvas. “Kanvas’s pioneering innovations will be a catalyst for brands to support better, safer consumer experiences through integrating higher quality software and smart-chip technology.” 

“BTV is thrilled to support Kanvas. With its innovative product proposition, strong management team, and now strategic partnership with BAT, we believe the Company is poised for success, and we welcome it to BTV’s portfolio,” says Lukasz Garbowski, BTV Investment Director. 

Ed Forsdike, Head of R&D, Beyond Nicotine at BAT, added, “We are excited to be partnering with the team at Kanvas and investing in this important new technology for the vaping category.”

Kanvas has a diverse portfolio of patents in technology, software, and hardware products to offer brands a comprehensive suite of premium solutions for electronic CBD, cannabis, and nicotine delivery systems, including its proprietary temperature-controlled dosing technology and software platform, Vapetelligence™.

About Btomorrow Ventures (BTV): 

BTV is the corporate venturing unit of British American Tobacco (BAT).  Established in 2020, BTV invests in high growth businesses, from seed funding to those looking for further, series B investment.  BTV’s focus is to invest in world-class entrepreneurs with innovative products, and differentiating technologies.  BTV supports BAT’s corporate purpose of building A Better Tomorrow™ and will accelerate its transformation into a multi-category consumer goods business.  For more information, visit our website:  http://www.btomorrowv.com.

About The Kanvas Co. (Kanvas):  

Kanvas® is a cannabis and nicotine technology company whose innovative software and hardware platform introduced temperature-controlled dosing technology and heating profiles that accurately and reliably deliver best-in-class vaporizing technology. Headquartered in Orange County, California, Kanvas provides safety, security, and performance through its patented software and hardware platform, Vapetelligence™. To learn more about Kanvas, please visit http://www.TheKanvasCo.com.

Latest news

Tilray’s Medical Cannabis Product Now Available And Reimbursed Under Ireland’s Medical Cannabis Access Program

PRESS RELEASE TILRAY Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and...

Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses

AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies...

MGC Pharma Announces Appointment Of UK Advisor And New COO/Deputy CEO

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') a European based bio-pharma company specialising in the production and development...

Sanity Group’s Record Funding Round Led By BAT Could Bring More Big-Tobacco Capital To Cannabis, But Concerns Remain Over Conflicts Of Interest

LAST week Berlin-based cannabis operator Sanity Group closed Europe’s largest ever cannabis investment round worth €37.6m, bringing its total...

European Cannabis Stocks Review: £22m Wiped From LSE-Listed Cannabis Stocks Amid Market Chaos

FOLLOWING a few weeks of relative positivity for many of the stocks listed on the London Stock Exchange (LSE),...

German SPD Representatives Confident A Solution To International Legal Hurdles Will Be Found

EARLIER this month news broke that recent analysis conducted by the Bundestag's scientific service suggested the creation of a...

Must read

You might also likeRELATED
Recommended to you